Thoracoabdominal Aortic Aneurysms
Not yet recruiting
- Conditions
- Thoracoabdominal Aortic Aneurysm
- Registration Number
- NCT06267573
- Lead Sponsor
- Assiut University
- Brief Summary
Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- all adult consecutive patients presenting with TAAA larger than 5.5 cm
Exclusion Criteria
- active infection Asymptomatic patients with small aneurysms Allergy to contrast agents
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Successful cannulation of the target vessels with complete in-line flow to target organs. Two years No ischemia
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the effectiveness of FEVAR and BEVAR devices in thoracoabdominal aortic aneurysm repair?
How does endovascular repair compare to open surgical repair in managing thoracoabdominal aortic aneurysms?
Which biomarkers are associated with favorable outcomes in patients undergoing endovascular treatment for TAAA?
What are the potential adverse events linked to FEVAR and BEVAR devices in TAAA management and their mitigation strategies?
Are there emerging technologies or competitor devices that could enhance thoracoabdominal aortic aneurysm treatment outcomes?